Andes Biotechnologies
21 September 2018
Andes Biotechnologies is a leading nucleic acid-based drug discovery and development company focused on solid tumor cancers.
You may be interested in...
-
New Q1 2025 LAVCA Industry Data; Apex Capital Acquires Majority Stake in Mexico’s Juanita’s Foods
-
SoftBank’s take on Blip; Thrive and Coatue’s new spins to tech investing
-
SoftBank Member Profile; Canary and Valor Capital Each Raise USD100m
-
LAVCA Q1 Data Sneak Peek; Kavak, Merama Updates; Igah Raises Fresh Capital